Pharmaceutical Business Review
Anonymous User | Login

Transgene's LiverCancer Drug Shows Efficacy In Animal Studies

Published: 10-Feb-2010

India-based Transgene Biotek (Transgene) has said that a new drug for liver cancer developed by its scientists has demonstrated improved efficacy in the latest animal studies. This corroborates earlier data gathered from the in-vitro studies.

Transgene has employed a novel gene silencing (within RNAi platform) technology to develop this drug.

The technology involves highly selective knock-down of specific liver cancer producing gene targets, which has demonstrated remarkable regression of the tumours in the animal studies, said the company.

Unlike Transgene's new hepatic cancer drug, traditional drugs used in cancer chemotherapy are non-selective, and induce DNA damage leading to tumor relapse.

Transgene has been involved in the development of technology for different bio-pharmaceuticals, recombinant vaccines and therapeutics.

Share

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

IRW

Full-Service Nordic Clinical Research Organisation (CRO) ...

Pharma IQ

Workshops, Conferences and Training Courses for Pharmaceutical Professionals ...

SGS

Life Science Services ...

INC Research

CRO for Drug and Device Development ...

World Courier

Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...

Pharmassist

Pharmaceutical Contract Research Organisation ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

No items to display

Suppliers Product News

INC Research Bolsters Regulatory Affairs Team for Europe and Asia

Geoff Fatzinger joins as executive director to manage regulatory readiness and strategic product development.

INC Research Underscores Importance of Clinical Delivery Alliances for More Efficient Drug Development Process

Tim Dietlin joins team as VP, Alliance Development.

World Courier CTSCS Depots Provide Dedicated Storage for GMO Products

In response to growing client demand and based on recently-established international biosafety regulations, World Courier has begun rolling out dedicated storage areas for GMO-derived pharmaceutical products throughout its global investigational drug storage network.

World Courier Triples Clinical Trial Storage Capacity Worldwide with Two New Facilities and Client-Driven Expansion

World Courier expands its GMP-compliant Clinical Trial Supply Chain Services (CTSCS) network, facilitating access to growing pharmaceutical markets in Africa and Australia.

World Courier Achieves Coveted GxP-Compliant Status Worldwide with Focus on GDP, Quality Management

With a fully GxP-compliant transport and supply chain system in place, World Courier meets the most demanding industry requirements for managing time- and temperature-sensitive clinical trial materials used in global studies.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address